Ledger.Open graph →
SEC Form D · filed November 23, 2016

EAGLE PHARMACEUTICALS, INC

Offering
$50.7M
Sold
$2.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WOODCLIFF LAKE, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Scott Tarriff · WOODCLIFF LAKE, NJExec · DirectorSteven E. Ratoff · WOODCLIFF LAKE, NJDirectorAdrian E. Hepner · WOODCLIFF LAKE, NJExecDavid E. Riggs · WOODCLIFF LAKE, NJExecSander E. Flaum · WOODCLIFF LAKE, NJDirectorDouglas L. Braunstein · New York, NYDirectorSteven L. Krill · WOODCLIFF LAKE, NJExecDavid E. Pernock · WOODCLIFF LAKE, NJDirectorMichael E. Graves · WOODCLIFF LAKE, NJDirectorRobert L. Glenning · WOODCLIFF LAKE, NJDirectorDavid E. Riggs · WOODCLIFF LAKE, NJExecSander E. Flaum · WOODCLIFF LAKE, NJDirectorScott Tarriff · WOODCLIFF LAKE, NJExec · DirectorDouglas L. Braunstein · New York, NYDirectorSteven L. Krill · WOODCLIFF LAKE, NJExecDavid E. Pernock · WOODCLIFF LAKE, NJDirectorMichael E. Graves · WOODCLIFF LAKE, NJDirectorSteven E. Ratoff · WOODCLIFF LAKE, NJDirectorRobert L. Glenning · WOODCLIFF LAKE, NJDirectorAdrian E. Hepner · WOODCLIFF LAKE, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗